Investigations in the assessment and management of patients with hirsutism

Current Opinion in Obstetrics and Gynecology

Volumn 9, Issue 3, 1997, Pages 187-192

  Barth, Julian H ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; FEMALE; HAIR GROWTH; HIRSUTISM; HUMAN; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REVIEW; TESTOSTERONE BLOOD LEVEL;

EID: 0030838027     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199706000-00010     Document Type: Review

References (44)

1. Shah PN: Human body hair: a quantitative study. Am J Obstet Gynecol 1957, 73:1255-1265.
2. Lunde O, Grottum P: Body hair growth in women: normal or hirsute. Am J Phys Anthropol 1984, 64:307-313.
3. Reynolds EL: The appearance of adult patterns of body hair in man. Ann N Y Acad Sci 1951, 53:576-584.
4. O'Driscoll JB, Mamtora H, Higginson J, Pollock A, Kane J, Anderson DC: A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. Clin Endocrinol (Oxf) 1994, 41:231-236.
5. Moran C, Tapia MC, Hernandez E, Vazquez G, Garcia-Hernandez E, Bermudez JA: Etiological review of hirsutism in 250 patients. Arch Med Res 1994, 25:311-314.
6. O'Driscoll JB, Anderson DC: Untreated congenital adrenal hyperplasia presenting with severe androgenic alopecia. J R Soc Med 1993, 86:229.
7. Derksen J, Nagesser SK, Meinders AE, Haak HR, van de Velde CJH: Identification of virilising adrenal tumours in hirsute women. N Engl J Med 1994, 331:968-973.
8. Woodruff JD, Parmley TH: Virilizing ovarian tumors. In Hirsutism and Virilism: Pathogenesis and Management. Edited by Mahesh VB, Greenblatt RB. London: Wright PSG; 1983:129-158.
9. Sandberg EC, Jackson JR: A clinical analysis of ovarian virilizing tumors. Am J Surg 1963, 105:784-792.
10. Moltz L, Pickartz H, Sorensen R, Schwartz U, Hammerstein J: Ovarian and adrenal vein steroids in seven patients with androgen-secreting ovarian neoplasms: selective catheterization findings. Fertil Steril 1984, 42:585-593.
11. Meldrum DR, Abraham GE: Peripheral and ovarian venous concentration of various steroid hormones in virilising ovarian tumours. Obstet Gynecol 1979, 53:36-43.
12. Barth JH: How hairy are hirsute women? Clin Endocrinol (Oxf) 1997 (in press).
13. Toscano V, Adamo MV, Caiola S, Foli S, Petrangeli E, Casilli D, Sciarra F: Is hirsutism an evolving syndrome? J Endocrinol 1983, 97:379-387.
14. el Tabbakh GH, Lofty I, Azab I, Rahman HA, Southren AL, Aleem FA: Correlation of the ultrasonic appearance of the ovaries in polycystic ovarian disease and the clinical, hormonal, and laparoscopic findings. Am J Obstet Gynecol 1986, 154:892-895.
15. Saxton DW, Farquhar CM, Rae T, Beard RW. Anderson MC, Wadsworth J: Accuracy of ultrasound measurements of female pelvic organs. Br J Obstet Gynaecol 1990, 97:695-699.
16. Eden JA: Which is the best test to detect the polycystic ovary? Aust N Z J Obstet Gynaecol 1988, 28:221-224.
17. Robinson S, Rodin DA, Deacon A, Wheeler MJ, Clayton RN: Which hormone tests for the diagnosis of polycystic ovary syndrome? Br J Obstet Gynaecol 1992, 99:232-238.
18. Fauser BCJM, Pache TD, Hop WCJ, de Jong FH, Dahl KD: The significance of a single LH measurement in women with cycle disturbances: discrepancies between immunoreactive and bioactive hormone estimates. Clin Endocrinol (Oxf) 1992, 37:445-452.
19. Fox R, Corrigan E, Thomas PA, Hull MG: The diagnosis of polycystic ovaries in women with oligo-amenorrhoea: predictive power of endocrine tests. Clin Endocrinol (Oxf) 1991, 34:127-131.
20. Koskinen P, Erkkola R, Penttila T-A, Irjala K, Anttila L: Optimal use of hormone determinations in the biochemical diagnosis of the polycystic ovary syndrome. Fertil Steril 1996, 65:517-522.
21. Fauser BCJM, de Jong FH: Gonadotropins in polycystic ovarian syndrome. Ann N Y Acad Sci 1993, 687:150-161.
22. Adams J, Poison DW, Franks S: Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. BMJ 1986, 293:355-359.
23. Obhrai M, Lynch SS, Holder G, Jackson R, Tang L, Butt WR: Hormonal studies on women with polycystic ovaries diagnosed by ultrasound. Clin Endocrinol (Oxf) 1990, 32:467-474.
24. Avivi I, Pollack S, Gideoni O, Linn S, Blumenfeld Z: Overdiagnosis of 21-hydroxylase late onset congenital adrenal hyperplasia: correlation of corticotropin test and human leukocyte antigen typing. Fertil Steril 1996, 66:557-563.
25. Spritzer P, Billaud L, Thalabard J-C, Birman P, Mowszowicz I, Raux-Demay M-C, Clair F, Kuttenn F, Mauvais-Jarvis P: Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia. J Clin Endocrinol Metab 1990, 70:642-646.
26. Philpott MP, Sanders DA, Kealey T: Effects of insulin and insulin-like growth factors on cultured human hair follicles: IGF-1 at physiologic concentrations is an important regulator of hair follicle growth in vitro. J Invest Dermatol 1994, 102:857-861.
27. Evans DJ, Barth JH, Burke CW: Body fat topography in women with androgen excess, Int J Obes 1988, 12:157-162.
28. De Pergola G, De Mitrio V, Perricci A, Cignarelli M, Garruti G, Lomuscio S, Ferri G, Schiraldi O, Giorgino R: Influence of free testosterone on antigen levels of plasminogen activator inhibitor-1 in premenopausal women with central obesity. Metabolism 1992, 41:131-134.
29. Conway GS, Agrawal R, Betteridge DJ, Jacobs HS: Risk factors for coronary heart disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992, 37:119-125.
30. Wild RA, Grubb B, Hartz A, van Nort JJ, Bachman W, Bartholomew M: Clinical signs of androgen excess as risk factors for coronary disease. Fertil Steril 1990, 54:255-259.
31. Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Oden A, Janson PO, Mattson L-A, Crona N, Lundberg P-A: Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long term follow up focussing on natural history and circulating hormones. Fertil Steril 1992, 57:505-513.
32. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L: Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. BMJ 1984, 289:1257-1261.
33. Apter D, Bützow T, Laughlin GA, Yen SSC: Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. J Clin Endocrinol Metab 1995, 80:2966-2973.
34. Ferriman D, Thomas PK, Purdie AW: Constitutional virilism. BMJ 1957, ii:1410-1412.
35. Bardin CW, Lipsett MB: Testosterone and androstenedione blood production rates in normal women and in women with idiopathic hirsutism or polycystic ovaries. J Clin Invest 1967, 46:891-902.
36. Thomas PK, Ferriman DG: Variation in facial and pubic hair growth in white women. Am J Phys Anthropol 1957, 15:171-180.
37. Barth JH, Jenkins M, Belchetz PE: Ovarian hyperthecosis, diabetes and hirsuties in post menopausal women. Clin Endocrinol (Oxf) 1997, 46:123-128.
38. Pepersack T, Rossi C, Dupuis F, Lefevre A, Vanhaever-beek M, Dekoninck W: Hormonal status and clinical relevance of hirsutism in elderly women. Acta Endocrinol (Copenh) 1993, 129:307-310.
39. Marcondes JA, Minnani SL, Luthold WW, Wajchenberg BL, Samojlik E, Kirschner MA: Treatment of hirsutism in women with flutamide. Fertil Steril 1992, 57:543-547.
40. Couzinet B, Pholsena M, Young J, Schaison G: The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism. Clin Endocrinol (Oxf) 1993, 39:157-162.
41. Dodin S, Faure N, Cedrin I, Mechain C, Turcot-Lemay L, Guy J, Lemay A: Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism. Clin Endocrinol (Oxf) 1995, 43:575-582.
42. Lookingbill DP, Egan N, Santen RJ, Demers LM: Correlation of serum 3α-androstanediol glucuronide with acne and chest hair density in men. J Clin Endocrinol Metab 1988, 67:986-991.
43. Rittmaster RS: Androgen conjugates: physiology and clinical significance. Endocrinol Rev 1993, 14:121-132.
44. Barth JH: How robust is the methodology for trials of therapy in hirsute women? Clin Endocrinol (Oxf) 1996, 45:379-380.